scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Astrazeneca Pharma India Ltd

Feedback
Astrazeneca Pharma India Ltd

Astrazeneca Pharma India Ltd (ASTRAZEN) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 36,217
Mar 12, 2025 15:59 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹7,706.85
₹-100.50 (-1.29%)
₹7675.7 Low
Today’s Performance
₹7957.15 High
₹4785 Low
52 Week’s Performance
₹8139 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -1.29%
  • 1 Week 6.86%
  • 1 Month 4.83%
  • 3 Months 17.97%
  • 6 Months 13.10%
  • 1 Year 45.26%
  • 3 Years 42.34%
  • 5 Years 26.05%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 2.00
  • Beta 0.56
  • 52-Week Low (₹) 4,785.00
  • 52-Week High (₹) 8,139.00
  • Price-to-Book (X)* 28.72
  • Dividend Yield (%) 0.31
  • Price-to-Earnings (P/E) (X)* 201.17
  • Earnings Per Share (₹) 38.79
  • Sector Price Earning (X)* 32.47
  • Market Cap (₹ Cr.)* 19,518.38
  • * Vaues as of last close price

COMPETITORS

BT TV

Elon Musk-Led SpaceX Dragon Spacecraft To Rescue Sunita Williams 2:22 Elon Musk-Led SpaceX Dragon Spacecraft To Rescue Sunita Williams
UP CM Yogi Adityanath Announces ₹1 Lakh Marriage Aid & Scooters For Meritorious Daughters 1:16 UP CM Yogi Adityanath Announces ₹1 Lakh Marriage Aid & Scooters For Meritorious Daughters
Ranya Gold Smuggling Probe Widens: BJP, Congress Face Off Over Political Links 2:18 Ranya Gold Smuggling Probe Widens: BJP, Congress Face Off Over Political Links
Lilavati Hospital Scandal: Rs 1,200 Crore Embezzlement & Black Magic Allegations! 4:29 Lilavati Hospital Scandal: Rs 1,200 Crore Embezzlement & Black Magic Allegations!
Elon’s Big Starlink Win In India: How Musk Overcame Ambani, 3:05 Elon’s Big Starlink Win in India: How Musk Overcame Ambani, Airtel, Regulators
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE
Sep 19, 2022 PURCHASE
ISHARES CORE MSCI EMERGING MARKETS ETF
  • Qty 74097
  • Average Price ₹3,152.55
Sep 19, 2022 Sell
ISHARES CORE EMERGING MARKETS MAURITIUS CO
  • Qty 74097
  • Average Price ₹3,152.55
Sep 19, 2022 PURCHASE
ISHARES MSCI INDIA SMALL-CAP ETF
  • Qty 6542
  • Average Price ₹3,152.55
Sep 19, 2022 Sell
ISHARES INDIA SC MAURITIUS COMPANY
  • Qty 6542
  • Average Price ₹3,152.55
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Apr 03, 2019 Sell
ICICI PRUDENTIAL MUTUAL FUND A/C VOLATILITY ADVANTAGE PLAN
  • Qty 125000
  • Average Price ₹2,000.00
May 30, 2013 Sell
CROSSEAS CAPITAL SERVICES PRIVATE LIMITED
  • Qty 126180
  • Average Price ₹845.63
May 30, 2013 PURCHASE
CROSSEAS CAPITAL SERVICES PVT. LTD.
  • Qty 131291
  • Average Price ₹844.46
May 30, 2013 Sell
CROSSEAS CAPITAL SERVICES PVT. LTD.
  • Qty 128849
  • Average Price ₹845.78
May 30, 2013 Sell
CROSSEAS CAPITAL SERVICES PRIVATE LIMITED
  • Qty 126180
  • Average Price ₹845.63
May 30, 2013 PURCHASE
CROSSEAS CAPITAL SERVICES PVT. LTD.
  • Qty 131291
  • Average Price ₹844.46
May 30, 2013 Sell
CROSSEAS CAPITAL SERVICES PVT. LTD.
  • Qty 128849
  • Average Price ₹845.78
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Astrazeneca Pharma India Ltd share price previously?
Astrazeneca Pharma India Ltd share price was down by -1.29% from the previous closing price of ₹7,807.35.
Who are peers of Astrazeneca Pharma India Ltd?
The peers of Astrazeneca Pharma India Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Mankind Pharma Ltd.
Who is/are the promoter/promoters of Astrazeneca Pharma India Ltd?
The promotor/promotors of Astrazeneca Pharma India Ltd are Narayan K Seshadri, Revathy Ashok, Shilpa Divekar Nirula, Sanjeev Panchal, Hooi Bien Chuah, Sylvia Lorena Varela Ramon, Bhavana Agrawal.
What has been 52-week high of Astrazeneca Pharma India Ltd stocks?
The highest price of Astrazeneca Pharma India Ltd stock is ₹8,139.00 in the last 52-week.
What is the share price of Astrazeneca Pharma India Ltd (ASTRAZEN) today on NSE?
As on Mar 12, 2025, Astrazeneca Pharma India Ltd (ASTRAZEN)’s share price on NSE is Rs 7706.85
What is the market cap of Astrazeneca Pharma India Ltd (ASTRAZEN?)
The current market capitalisation of Astrazeneca Pharma India Ltd (ASTRAZEN) is 19,518.38 crores
What is Astrazeneca Pharma India Ltd Share symbol?
The symbol of Astrazeneca Pharma India Ltd is ASTRAZEN.
What is the PE ratio of Astrazeneca Pharma India Ltd (ASTRAZEN)?
The current PE ratio of Astrazeneca Pharma India Ltd (ASTRAZEN) is 201.17.
What is the PB ratio of Astrazeneca Pharma India Ltd (ASTRAZEN)?
The current PB ratio of Astrazeneca Pharma India Ltd (ASTRAZEN) is 28.72.
Today’s High & Low share prices of Astrazeneca Pharma India Ltd (ASTRAZEN) on NSE?
Today, the share price of Astrazeneca Pharma India Ltd (ASTRAZEN) on NSE touched a high of Rs 7957.15 and a low of Rs 7675.7
What price did Astrazeneca Pharma India Ltd (ASTRAZEN) shares open on the NSE today?
On NSE, the share price of Astrazeneca Pharma India Ltd (ASTRAZEN) opened at Rs 7807.35
What is the 52-week high of Astrazeneca Pharma India Ltd (ASTRAZEN)?
The 52-week high price of Astrazeneca Pharma India Ltd (ASTRAZEN) is Rs 8139
What is the 52-week low of Astrazeneca Pharma India Ltd (ASTRAZEN) ?
The 52-week low price of Astrazeneca Pharma India Ltd (ASTRAZEN) is Rs 4785

ABOUT ASTRAZENECA PHAR

Astrazeneca Pharma India Ltd, incorporated in the year 1979, has its registered office in Blk N1 12th Flr Manyata Embass, Rachenahalli Outer Ring Road, Bangalore, Karnataka, 560045, 91-080-67748000, 91-080-67748557. The main industry in which Astrazeneca Pharma India Ltd operates is Pharmaceuticals - Multinational.

Auditor/Auditors for Astrazeneca Pharma India Ltd is/are Price Waterhouse Chartered Accountants LLP. In the main management, Narayan K Seshadri is chairman and is the company secretary for Astrazeneca Pharma India Ltd.

  • NKS Narayan K Seshadri Chairman & Independent Directo
  • RA Revathy Ashok Non-Exec. & Independent Dir.
  • SDN Shilpa Divekar Nirula Non-Exec. & Independent Dir.
  • SP Sanjeev Panchal Managing Director
  • HBC Hooi Bien Chuah Non Executive Director
  • SLVR Sylvia Lorena Varela Ramon Non Executive Director
  • BA Bhavana Agrawal Executive Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement